Volume 15, Issue 1 (January & February 2024)                   BCN 2024, 15(1): 81-88 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Karimi N, Akha O, Rezaiefard J. Assessment of the Carpal Tunnel Syndrome in Female Patients With Hypothyroidism. BCN 2024; 15 (1) :81-88
URL: http://bcn.iums.ac.ir/article-1-2362-en.html
1- Immunogenetics Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
2- Diabetes Research Center, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
3- Clinical Research Development Unit, Bou Ali Sina Hospital, Mazandaran University of Medical Sciences, Sari, Iran.
Full-Text [PDF 552 kb]       |   Abstract (HTML) 
Full-Text:  
1. Introduction
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy, caused by compression of the median nerve in the wrist (Nazish et al., 2019). King Fahd Hospital of University, Al-Khobar, Kingdom of Saudi Arabia from April 2017 to March 2018 and included 200 patients with CTS. Body parameters, such as blood pressure (BP). The prevalence of CTS varies among different populations. A recent study in Iran reported a prevalence of 1.82% for CTS in the general population (2.23% among females and 0.58% among males) (Moosazadeh et al., 2018). A hallmark of this disorder is pain, paresthesia, and burning along the pathway of the median nerve. In advanced stages, weakness and atrophy of the muscles in the thenar region develop, leading to difficulty in performing activities (Stevens et al., 1992). Diagnosis of the syndrome is based on clinical symptoms, physical examination, and electrodiagnostic tests (Karimi et al., 2021; Razavi et al., 2021). Several risk factors contribute to the development of CTS, including age, obesity, diabetic mellitus, rheumatoid arthritis, smoking, pregnancy, hypothyroidism, congenital anomalies, and wrist injury (Karimi et al., 2017; Moghtaderi et al., 2005). Evidence suggests that hypothyroidism is a significant predisposing factor for CTS, with reported prevalence rates ranging from 8.7% (Karimi et al., 2017) to 38.2% among CTS patients with subclinical hypothyroidism (Roshanzamir et al., 2016). Studies have indicated that most hypothyroid patients with CTS have mild forms of the syndrome, with none experiencing severe CTS (Asadi & Roshanzamir, 2017; Beghi et al., 1989; Karne & Bhalerao, 2016).
There are several theories regarding the pathogenesis of CTS, including alterations in fluid balance, dermal edema, excess deposition of glycosaminoglycans, hyaluronic, acid, and mucopolysaccharides in subcutaneous tissues, and dysfunction of myelin and axonal processes (Beghi et al., 1989; Karne & Bhalerao, 2016). Hypothyroidism is known to increase body mass index (BMI) and obesity and has been identified as an independent risk factor for CTS. However, the extent of CTS severity in hypothyroid patients remains unclear. To date, only a few studies have investigated the role of hypothyroidism in CTS severity. Considering that the severity of clinical symptoms affects treatment outcomes, the aim of this study was to assess the severity of CTS in hypothyroid patients. 

2. Materials and Methods

Study design

This retrospective cross-sectional study was conducted at the University Clinic Bagheban in Sari City, Mazandaran Province, Iran, from December 2018 to February 2020. 

Setting and participants
All female patients who were referred to our electrophysiology clinic with clinical symptoms of CTS containing numbness, tingling, paresthesia, pain, burning feeling, and weakness in unilateral or bilateral hand or wrist, were examined (AANEM et al., 2002). After a physical examination, the electrodiagnostic test was done for confirmation of CTS. Due to the effect of occupation and gender on CTS, all contributors in this research were housewives and females. CTS patients ≥18 years old who had hypothyroid and were being treated with thyroxine were included in the study, along with patients with idiopathic CTS. Exclusion criteria included pregnancy, hyperthyroidism, diabetes mellitus, other endocrinal diseases, connective tissue diseases, arthritis, wrist fractures, renal and liver diseases, acromegaly, neuropathy, radiculopathy, and aforementioned CTS surgery.
Overall, 76 patients who had a clinically and electrophysiologically confirmed diagnosis of CTS were included in the study. All female patients presenting with clinical symptoms of CTS, including numbness, tingling, paresthesia, pain, burning sensation, and weakness in one or both hands or wrists, were evaluated at our electrophysiology clinic (AANEM et al., 2002). Following a physical examination, electrodiagnostic testing was performed to confirm the diagnosis of CTS. Given the influence of occupation and gender on CTS, all participants in this study were female housewives.
The study included CTS patients aged 18 years and older who had hypothyroidism and were undergoing treatment with thyroxine, as well as patients with idiopathic CTS. Exclusion criteria comprised pregnancy, hyperthyroidism, diabetes mellitus, other endocrine disorders, connective tissue diseases, arthritis, wrist fractures, renal and liver diseases, acromegaly, neuropathy, radiculopathy, and previous CTS surgery.
A total of 76 patients with clinically and electrophysiologically confirmed CTS were enrolled in the study.

Data sources and measurement
All participants completed the Boston carpal tunnel questionnaire (BCTQ) and provided demographic data including, age, educational level, affected hand, duration of the disease, weight, height, and BMI. BCTQ investigates the severity of patient’s symptoms and their ability to perform daily tasks. It contains 19 questions (11 items related to the severity of symptoms and 8 items allied to functional ability). Each question is scored on a scale of five, ranging from no symptoms to very severe. The scores are totaled for each individual, with higher scores indicating more intense symptoms and disability (Levine et al., 1993). CTS severity was evaluated according to BCTQ and electrophysiological parameters. The electrodiagnostic test was conducted by a neurologist following the guidelines of the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM), using a Micromed MYOQUICK model electromyography apparatus (Jablecki et al., 2002). Electrophysiological findings were categorized into six grades, ranging from normal to extremely severe CTS, in accordance with the Bland neurophysiological grading scale (Bland, 2000). The parameters measured included peak latency, amplitude, and conduction velocity of the sensory median nerve, and distal latency, amplitude, and conduction velocity of the motor median nerve. Needle electromyography was performed on the abductor pollicis brevis muscle and other muscles in the upper limb to assess the severity of CTS and exclude brachial plexopathy or radiculopathy. electrodiagnostic results were considered abnormal if peak latency was >3.5 ms, base-to-peak amplitude was <20.0 μV, conduction velocity was <50 m/s studies, distal motor latency was >4.4 ms, base-to-peak amplitude was <4.0 mV, and nerve conduction velocity (NCV) was <49 m/s (Ali et al., 2012; Basiri & Katirji, 2015). Electrophysiological studies were performed on both hands, and the hand with the most severe electrophysiological findings was evaluated. 

Statistical analysis
All analyses were performed using SPSS software, version 24. The one-sample Kolmogorov-Smirnov-test was used to test for normality; the results of this test indicated that parametric tests should be performed. Quantitative data were presented as Mean±SD, while qualitative data were described in terms of frequency and percentage. An independent sample t-test was conducted to assess quantitative data between the two groups (electrodiagnostic parameter findings and severity of CTS according to Boston score in hypothyroid and non-hypothyroid patients). A chi-squared test was applied to assess the relationship between categorical variables and qualitative data. A P<0.05 was considered significant. 

3. Results
Seventy-six patients with clinical and electrodiagnostic evidence of CTS were included in this study between December 2018 to February 2020, of whom 38 patients had hypothyroidism and 38 participants had idiopathic CTS (without hypothyroidism). The mean age of all patients was 45.02±7.74 years. Unilateral and bilateral CTS were in 26(34.2%) and 50(65.8%) patients, respectively. The patients had a BMI of 31.47±5.26 kg/m2, with a minimum of 21.5 to a maximum of 45 kg/m2. The mean durations of CTS and hypothyroidism were 29.61±32.29 and 98.93±64.19 months, respectively. 

Comparison of CTS patients with and without hypothyroid disease 
Thirty-eight of the CTS patients had hypothyroidism and 38 did not. There was no significant difference between hypothyroid and non-hypothyroid CTS patients in terms of age (46.21±7.22 years vs. 44.24±8.02 years, P=0.225), duration of CTS (31.89±32.13 and 28.24±32.60 months, P=0.609), and BMI (30.78±5.29 and 31.89±5.29 kg/m2, P=0.326). Bilateral CTS was present in 24(63.2%) of the 38 patients with hypothyroidism and in 26(68.4%) of the 38 patients without hypothyroidism (P=0.22). The demographic and clinical characteristics of the study participants are presented in Table 1



Comparison of the Boston questionnaire score in hypothyroid and non-hypothyroid-CTS patients
The mean score of the symptom severity scale (SSS) in hypothyroid CTS patients and non-hypothyroid CTS patients was 30.37±10.84 and 35.89±7.19, respectively. Similarly, the mean score of the functional status scale (FSS) was 21.71±9.04 and 25.92±6.62, respectively. There was a significant difference between the two groups in terms of SSS (P=0.017; 95% CI, 31.14%, 35.48%) and FSS (P=0.023; 95% CI, 21.95%, 25.67%) scores. 
Comparison of the electrophysiological parameters in hypothyroid and non-hypothyroid CTS patients
The electrodiagnostic findings, such as median nerve sensory onset latency, peak latency, amplitude, and conduction velocity, as well as median nerve motor distal latency, amplitude, and conduction velocity, were measured in the involved hands of all participants. There was no significant difference in respect to electrophysiological parameter results between the two groups. The majority of participants in hypothyroid CTS and non-hypothyroid CTS had moderate CTS (29.70% and 34.51%, respectively). The chi-square test found no significant differences between the two groups according to Bland’s grading of electrodiagnostic findings (Figure 1).



The mean score was obtained for each electrophysiological parameter in hypothyroid and non-hypothyroid CTS patients (Table 2). No statistically significant difference was observed between these two groups. 




The relationship between the electrodiagnostic grading and Boston score
To evaluate the relationship between electrodiagnostic grading and clinical symptoms, mild to moderate CTS cases were grouped separately from severe to extremely severe CTS cases. Independent t-test analysis revealed no statistically significant association between electrodiagnostic grading and SSS and FSS scores in the hypothyroidism group (Table 3). Conversely, there was a significant positive association between electrodiagnostic grading and clinical symptoms (P=0.01; 95% CI, 33.52%, 38.26%) as well as FSS (P=0.002; 95% CI, 23.74%, 28.09%) in non-hypothyroidism CTS patients. The results of this analysis are presented in Table 3.




4. Discussion
Hypothyroidism is considered a risk factor for the development of CTS (Karimi et al., 2017; Farzan et al., 2012; Shiri, 2014) but the severity of CTS in hypothyroid patients undergoing treatment remains unclear. The aim of this study was to compare the severity of CTS between treated hypothyroid and non-hypothyroid patients. This study specifically targeted housewives to mitigate the confounding effect of gender and occupation on CTS. The mean age of hypothyroid and non-hypothyroid CTS patients was similar. Additionally, the mean BMI was above 30 kg/m2 in both groups, consistent with previous research (Becker et al., 2002). Regarding demographic data, hypothyroid patients were comparable to non-hypothyroid patients. The study findings revealed that the clinical symptoms of CTS were more severe in non-hypothyroid patients compared to treated hypothyroid patients. This contradicts the findings of Asadi and Roshanzamir, who reported that the clinical symptoms of hypothyroid patients were more severe than those of non-hypothyroid patients (Asadi & Roshanzamir, 2017). 
In our study, all of the hypothyroid patients were undergoing hormone replacement therapy. Therefore, treatment may effectively reduce the severity of patients’ clinical symptoms. Kasem et al.’s study demonstrated the effectiveness of hormone replacement therapy in alleviating CTS symptoms (Kasem et al., 2014). In the present study, age and BMI in the hypothyroid and non-hypothyroid patients were comparable. Therefore, we believe that thyroxine replacement therapy may contribute to alleviating the severity of patients’ clinical symptoms. Additionally, our study found no association between the severity of CTS based on electrophysiological findings in hypothyroid and non-hypothyroid CTS patients. These findings align with those of Asadi and Roshanzamir’s study (Asadi & Roshanzamir, 2017). 
This study showed that although hypothyroidism is considered a possible risk factor for CTS in previous research (Cruz et al., 1999; El-Salem & Ammari, 2006), there is no evidence to suggest that hypothyroidism influences the severity of electrophysiological parameters. Regarding the correlation between clinical symptoms and electrodiagnostic grading in CTS, our findings indicated that the severity of clinical symptoms and functional impairment, as assessed by the Boston score, is more closely associated with the grading of the electrodiagnostic test in non-hypothyroid CTS patients. Surprisingly, this relationship was not observed in hypothyroidism patients. This finding aligns with that of Asadi and Roshanzamir who found no relationship between clinical symptoms and electrodiagnostic findings in patients with hypothyroidism (Asadi & Roshanzamir, 2017). These results could be explained by the possibility that the severity of clinical symptoms is directly related to median nerve damage. Furthermore, the lack of correlation between clinical symptoms and electrodiagnostic grading in hypothyroid patients may be attributed to the role of thyroid replacement therapy in symptom reduction, regardless of its impact on electrodiagnostic parameters. Aldaghri et al. reported that more than two-thirds of individuals with hypothyroidism were asymptomatic, and the presence of thyroid abnormality did not affect the duration of CTS (Aldaghri et al., 2020).

5. Conclusion 
The results of this study suggest that the severity of CTS may be higher in non-hypothyroid patients compared to hypothyroid patients. Thus, it can be inferred that thyroid replacement therapy plays a role in reducing clinical symptoms. This warrants further investigation in future research.

Ethical Considerations

Compliance with ethical guidelines

The present study was approved by the Ethics Committee of Mazandaran University of Medical Sciences (Code: 5.7.96).

Funding
This research was extracted from the medical thesis of Javad Rezaeifard, approved by Mazandaran University of Medical Sciences (Project No.: 10201) and was financially supported by the Mazandaran University of Medical Sciences.

Authors' contributions
Conceptualization and supervision: Narges Karimi, Ozra Akha and Javad Rezaeifard; Methodology: Narges Karimii; Data collection: Narges Karimi and Ozra Akha; Data analysis: Narges Karimi and Javad Rezaeifard; Funding acquisition and resources: Narges Karimi; Investigation and writing: All authors. 

Conflict of interest
The authors declared no conflict of interest.

Acknowledgments
The authors thank all the patients who participated in this study, the Research Vice-Chancellor of Mazandaran University of Medical Sciences for financial support, and the Clinical Research Development Unit of Bou Ali Sina Hospital for approving the research proposal.




References
Aldaghri, F., Algahtani, M. S., Almutairi, T. A., Albusair, M., Bin Ghali, K., & Al Asim, F. S. (2020). Prevalence of hypothyroidism among carpal tunnel syndrome patients at a hospital in Saudi Arabia. Cureus, 12(12), e12264. [DOI:10.7759/cureus.12264] [PMID]  
Ali, Z., Khan, A., Shah, S. M. A., & Zafar, A. (2012). Clinical and electro-diagnostic quantification of the severity of carpal tunnel syndrome. Annals of Pakistan Institute of Medical Sciences, 8(4), 207-12. [Link]
American Association of Electrodiagnostic Medicine, American Academy of Neurology, and American Academy of Physical Medicine and Rehabilitation (2002). Practice parameter for electrodiagnostic studies in carpal tunnel syndrome: Summary statement. Muscle & Nerve, 25(6), 918-922. [DOI:10.1002/mus.10185] [PMID] 
Asadi, M., & Roshanzamir, S. (2017). Electrodiagnostic criteria for diagnosing carpal tunnel syndrome need to be revised in hypothyroid patients. Journal of Musculoskeletal Research, 20(3), 1750014. [DOI:10.1142/S0218957717500142] 
Basiri, K., & Katirji, B. (2015). Practical approach to electrodiagnosis of the carpal tunnel syndrome: A review. Advanced Biomedical Research, 4, 50. [DOI:10.4103/2277-9175.151552] [PMID]  
Becker, J., Nora, D. B., Gomes, I., Stringari, F. F., Seitensus, R., & Panosso, J. S., et al. (2002). An evaluation of gender, obesity, age and diabetes mellitus as risk factors for carpal tunnel syndrome. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology, 113(9), 1429-1434. [DOI:10.1016/s1388-2457(02)00201-8] [PMID] 
Beghi, E., Delodovici, M. L., Bogliun, G., Crespi, V., Paleari, F., & Gamba, P., et al. (1989). Hypothyroidism and polyneuropathy. Journal of Neurology, Neurosurgery, and Psychiatry, 52(12), 1420-1423. [DOI:10.1136/jnnp.52.12.1420] [PMID]  
Bland, J. D. (2000). A neurophysiological grading scale for carpal tunnel syndrome. Muscle & Nerve, 23(8), 1280-1283. [DOI:10.1002/1097-4598(200008)23:83.0.co;2-y] [PMID] 
Cruz, J. M., Martínez, R., Urdiales, J., & Zarzalejos, J. M. (1999).  [The carpal tunnel syndrome and hypothyroidism (Spanish)]. Anales de Medicina Interna (Madrid, Spain: 1984), 16(7), 386. [PMID]
El-Salem, K., & Ammari, F. (2006). Neurophysiological changes in neurologically asymptomatic hypothyroid patients: A prospective cohort study. Journal of Clinical Neurophysiology: Official Publication of the American Electroencephalographic Society, 23(6), 568-572. [DOI:10.1097/01.wnp.0000231273.22681.0e] [PMID] 
Jablecki, C. K., Andary, M. T., Floeter, M. K., Miller, R. G., Quartly, C. A., & Vennix, M. J., et al. (2002). Practice parameter: Electrodiagnostic studies in carpal tunnel syndrome. Report of the American Association of Electrodiagnostic Medicine, American Academy of Neurology, and the American Academy of Physical Medicine and Rehabilitation. Neurology, 58(11), 1589-1592. [DOI:10.1212/wnl.58.11.1589] [PMID] 
Karimi, N., AbedianKenari, S., & Darvari, F. (2021). Serum levels of inflammatory cytokines in patients with idiopathic carpal tunnel syndrome. The International Journal of Neuroscience, 131(3), 228-232. [DOI:10.1080/00207454.2020.1737050] [PMID] 
Karimi, N., Tabrizi, N., Moosavi, M., & Yadani charatti, J. (2017). [Prevalence of carpal tunnel syndrome and associated risk factors (Persian)]. Journal of Mazandaran University of Medical Sciences, 26(146), 179-184. [Link]
Karne, S. S., & Bhalerao, N. S. (2016). Carpal Tunnel Syndrome in Hypothyroidism. Journal of Clinical and Diagnostic Research : JCDR, 10(2), OC36-OC38. [DOI:10.7860/JCDR/2016/16464.7316] [PMID]  
Kasem, A. A., Fathy, S. M., Shahin, D. A., & Fikry, A. A. (2014). Carpal Tunnel Syndrome in hypothyroid patients: The effect of hormone replacement therapy. American Journal of Internal Medicine, 2(3), 54. [DOI:10.11648/j.ajim.20140203.14] 
Levine, D. W., Simmons, B. P., Koris, M. J., Daltroy, L. H., Hohl, G. G., & Fossel, A. H., et al. (1993). A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. The Journal of Bone and Joint Surgery. American Volume, 75(11), 1585–1592.[DOI:10.2106/00004623-199311000-00002] [PMID] 
Farzan, M., Mazochi, H., Sobhani, A., Shajirat, Z., Zolfaghari, R., &Spandar, R.  (2012). [Carpal tunnel syndrome and contributing factors in 362 hospitalized patients (Persian)]. Tehran University Medical Journal, 70(1), 27-32. [Link]
Moghtaderi, A., Izadi, S., & Sharafadinzadeh, N. (2005). An evaluation of gender, body mass index, wrist circumference and wrist ratio as independent risk factors for carpal tunnel syndrome. Acta Neurologica Scandinavica, 112(6), 375-379. [DOI:10.1111/j.1600-0404.2005.00528.x] [PMID] 
Moosazadeh, M., Asadi-Aliabadi, M., Rostami, F., Farshidi, F., & Karimi, N. (2018). [Prevalence of carpal tunnel syndrome in Iran: A systematic review and meta-analysis (Persian)]. Journal of Mazandaran University of Medical Sciences, 28(161), 144-153. [Link]
Nazish, S., Zafar, A., Shahid, R., Al Sulaiman, A., Alabdali, M., & Aljaafari, D., et al. (2019). Electrophysiologic severity of carpal tunnel syndrome in diabetic patients of the Saudi population. Neurosciences (Riyadh, Saudi Arabia), 24(1), 22-28. [DOI:10.17712/nsj.2019.1.20180217] [PMID]  
Razavi, A. S., Karimi, N., & Bashiri, F. (2021). The relationship of serum lipid profiles and obesity with the severity of carpal tunnel syndrome. The Pan African Medical Journal, 39, 90. [DOI:10.11604/pamj.2021.39.90.27234] [PMID]  
Roshanzamir, S., Azarang, A., & Dabbaghmanesh, A. (2016). Rational for hypothyroidism screening in carpal tunnel syndrome patients without definite predisposing factor. Journal of Musculoskeletal Research, 19(04), 1650020. [DOI:10.1142/S0218957716500202]
Shiri, R. (2014). Hypothyroidism and carpal tunnel syndrome: A meta-analysis. Muscle & Nerve, 50(6), 879-883. [DOI:10.1002/mus.24453] [PMID] 
Stevens, J. C., Beard, C. M., O'Fallon, W. M., & Kurland, L. T. (1992). Conditions associated with carpal tunnel syndrome. Mayo Clinic Proceedings, 67(6), 541-548. [DOI:10.1016/s0025-6196(12)60461-3] [PMID] 
Type of Study: Original | Subject: Clinical Neuroscience
Received: 2021/09/28 | Accepted: 2021/12/5 | Published: 2024/01/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb